Borago Lavender

The dosage of Borage varies significantly based on the condition being treated and the concentration of gamma-linolenic acid (GLA) in the specific product. For general anti-inflammatory support, healthcare providers typically suggest a dose of 1,000 mg to 3,000 mg of Borage oil daily. This usually provides approximately 240 mg to 720 mg of active GLA. In clinical studies focusing on rheumatoid arthritis, higher doses of up to 2.8 grams of GLA per day have been utilized, but such high-level supplementation must only be conducted under strict medical supervision. For allergic testing, the dosage is determined by the specific diagnostic protocol used by the allergist and is administered in a controlled clinical environment.

Borage is generally not recommended for use in infants or young children unless specifically directed by a pediatric specialist. While some studies have explored the use of Borage oil for pediatric atopic dermatitis, the data remains inconclusive. If a physician determines that Borage is necessary for a child, the dosage is typically weight-based, often starting at a much lower threshold (e.g., 500 mg of oil daily). Parents must ensure that any product used for children is certified 'PA-free' to prevent the risk of hepatic veno-occlusive disease.

Renal Impairment

There are no specific standardized dosage adjustments for patients with renal (kidney) impairment. However, because Borage may have mild diuretic and acidifying effects, patients with chronic kidney disease (CKD) should be monitored closely for changes in electrolyte balance and renal function. Your doctor may choose to start at the lower end of the dosing spectrum.

Hepatic Impairment

Patients with pre-existing hepatic (liver) impairment should exercise extreme caution. Even 'PA-free' Borage products may place additional metabolic stress on the liver. In many cases, Borage is contraindicated in patients with active liver disease or significantly elevated liver enzymes. If used, frequent liver function tests (LFTs) are mandatory.

Elderly Patients

Elderly patients often have decreased hepatic and renal clearance. For this population, healthcare providers usually recommend starting with a low dose (e.g., 500 mg daily) and titrating upward slowly while monitoring for side effects like gastrointestinal distress or increased bruising, which may result from Borage's anti-coagulant properties.

To maximize the benefits and minimize the risks of Borage, follow these specific instructions:

• With Food: Borage oil capsules should be taken with a meal that contains some fat. This significantly improves the absorption of GLA and reduces the likelihood of gastrointestinal side effects like 'borage burps' or nausea.
• Swallow Whole: Do not crush or chew Borage oil capsules. The oil has a distinct taste that many find unpleasant, and the capsule is designed to release the oil in the stomach or intestine.
• Consistency: For anti-inflammatory effects, Borage must be taken consistently. It may take 6 to 12 weeks of daily use before a noticeable improvement in symptoms occurs.
• Storage: Borage oil is highly susceptible to oxidation (rancidity). Store the bottle in a cool, dry place, away from direct sunlight. Many clinicians recommend refrigerating Borage oil after opening to maintain its potency.

If you miss a dose of Borage, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up, as this increases the risk of gastrointestinal upset and potential anti-coagulant effects.

An acute overdose of Borage oil is rarely life-threatening but can cause significant distress. Signs of an overdose include:

• Severe diarrhea and abdominal cramping
• Nausea and vomiting
• Increased bleeding or bruising
• Headache or dizziness

In the event of a massive ingestion, seek emergency medical attention or contact a poison control center immediately. Treatment is generally supportive, focusing on hydration and monitoring of liver enzymes and coagulation profiles.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or start Borage without medical guidance, especially if you are taking other medications or have underlying health conditions.

Borage is generally well-tolerated when used at standard doses, but some patients may experience mild adverse effects. The most common side effects involve the gastrointestinal system. These include:

• Gastrointestinal Upset: This may manifest as bloating, gas, or a feeling of fullness. Taking the supplement with food often mitigates these symptoms.
• Soft Stools: Due to the high lipid content, some patients may experience a mild laxative effect, leading to softer stools or more frequent bowel movements.
• Nausea: A feeling of queasiness shortly after ingestion is common, particularly if taken on an empty stomach.

• Headache: Some users report mild tension-type headaches during the first few days of supplementation as the body adjusts to the fatty acid changes.
• Skin Rash: In rare cases, individuals may develop a mild, itchy rash (urticaria) even if they are not specifically allergic to the plant extract.
• Belching: Often referred to as 'fishy' or 'oily' burps, this is a common complaint with high-dose oil supplements.

• Seizures: There have been isolated reports of Borage oil lowering the seizure threshold, particularly in patients with a history of epilepsy or those taking medications that also lower the threshold (like phenothiazines).
• Easy Bruising: Due to its anti-coagulant properties, some patients may notice that they bruise more easily or that small cuts take longer to stop bleeding.

> Warning: Stop taking Borage and call your doctor immediately if you experience any of these serious symptoms. These may indicate toxicity or a severe allergic reaction.

1. 1Hepatotoxicity (Liver Damage): Symptoms include yellowing of the skin or eyes (jaundice), dark urine, severe right-sided abdominal pain, and unexplained fatigue. This is most often associated with products containing pyrrolizidine alkaloids.
2. 2Anaphylaxis: A severe allergic reaction characterized by swelling of the face, lips, or tongue, difficulty breathing, wheezing, and a rapid drop in blood pressure.
3. 3Severe Abdominal Pain: This could indicate hepatic veno-occlusive disease, a rare but life-threatening condition where the small veins in the liver become blocked.
4. 4Uncontrolled Bleeding: If you experience a nosebleed that won't stop, blood in your urine, or black, tarry stools, seek emergency care immediately.

Prolonged use of Borage, especially if the product is not certified PA-free, can lead to chronic liver congestion and fibrosis. There is also a theoretical risk that long-term high-dose GLA supplementation could interfere with the balance of other essential fatty acids, such as omega-3s, potentially affecting cardiovascular health or inflammatory balance in unforeseen ways. Regular blood work to monitor liver enzymes is recommended for anyone using Borage long-term.

Currently, there are no FDA-mandated black box warnings for Borage as a dietary supplement or non-standardized extract. However, several international health regulatory agencies have issued strong warnings regarding the presence of pyrrolizidine alkaloids (PAs) in Borage products. These warnings emphasize that PAs are cumulative toxins that can cause permanent liver damage and increase the risk of cancer. Patients are strongly advised to only use products that have been laboratory-tested and verified to be PA-free.

Report any unusual symptoms to your healthcare provider. Your clinical team can help determine if a side effect is transient or requires discontinuation of the supplement.

Borage is a potent pharmacological agent that must be handled with care. The most critical safety point is the source and purity of the Borage extract. Because Borage naturally contains pyrrolizidine alkaloids (PAs), which are toxic to the liver, patients must verify that their product is 'PA-free.' Additionally, Borage can influence blood clotting and the nervous system's stability. It is not a 'simple herb' and should be treated with the same respect as a prescription medication.

No FDA black box warnings for Borage. However, clinicians should note that the absence of a black box warning does not imply absolute safety, particularly regarding the risk of hepatic veno-occlusive disease from non-purified extracts.

• Allergic Reactions / Anaphylaxis Risk: As a member of the Boraginaceae family, Borage can cause cross-reactivity in individuals allergic to other plants in the same family or those with sensitivities to ragweed or daisies. Anaphylaxis is rare but possible, especially with injectable allergenic extracts.
• Hepatotoxicity: The liver is the primary organ at risk. Patients with a history of hepatitis, cirrhosis, or heavy alcohol use are at a significantly higher risk for adverse effects. Even small amounts of PAs can be cumulative over time.
• Seizure Disorders: Borage may lower the seizure threshold. This means it could make a seizure more likely to occur in people who are prone to them. Patients with epilepsy or a history of head injury should avoid Borage unless cleared by a neurologist.
• Bleeding Risk: Because of its anti-coagulant properties, Borage should be used cautiously in patients with bleeding disorders or those scheduled for surgery. It is typically recommended to discontinue Borage at least two weeks before any elective surgical procedure.

If you are taking Borage for a chronic condition, your healthcare provider may require the following tests:

• Liver Function Tests (LFTs): To monitor levels of ALT, AST, and bilirubin, ensuring the liver is processing the supplement safely.
• Coagulation Profile (PT/INR): To check how quickly your blood clots, especially if you are also taking blood thinners.
• Lipid Panel: To monitor the impact of the fatty acids on your overall cholesterol and triglyceride levels.

Borage generally does not cause drowsiness or cognitive impairment. However, if you experience dizziness or headaches when starting the supplement, you should avoid driving or operating heavy machinery until you know how the substance affects you.

Alcohol consumption should be strictly limited while taking Borage. Alcohol is a known hepatotoxin, and combining it with Borage (which may contain trace PAs or otherwise stress the liver) significantly increases the risk of liver damage. Furthermore, alcohol can exacerbate the gastrointestinal side effects of Borage oil.

There is no known withdrawal syndrome associated with Borage. However, if you are taking it for an inflammatory condition like rheumatoid arthritis, stopping the supplement suddenly may lead to a 'flare' or worsening of your symptoms. It is best to discuss a tapering schedule with your doctor if you wish to stop taking it.

> Important: Discuss all your medical conditions, including any history of liver disease, seizures, or bleeding problems, with your healthcare provider before starting Borage.

Certain medications should never be combined with Borage due to the high risk of severe adverse events:

• Phenothiazines (e.g., Chlorpromazine, Prochlorperazine): These antipsychotic and anti-nausea medications are known to lower the seizure threshold. Combining them with Borage oil significantly increases the risk of a major motor seizure. This combination is considered a major contraindication.
• Hepatotoxic Drugs (e.g., Methotrexate, Amiodarone): Using Borage alongside other drugs known to damage the liver creates a synergistic toxic effect, potentially leading to acute liver failure.

• Anticoagulants and Antiplatelets (e.g., Warfarin, Clopidogrel, Aspirin): Borage has inherent anti-coagulant properties. When taken with these medications, it can excessively thin the blood, leading to an increased risk of internal bleeding, bruising, and prolonged bleeding from minor injuries. Your doctor will need to monitor your INR or PT levels very closely.
• NSAIDs (e.g., Ibuprofen, Naproxen): While both are used for inflammation, taking them together can increase the risk of gastrointestinal bleeding and may affect renal blood flow.

• CYP3A4 Inducers (e.g., Rifampin, St. John's Wort, Carbamazepine): These substances speed up the liver's metabolism. If the Borage product contains any trace pyrrolizidine alkaloids, these inducers will convert them into toxic pyrroles much faster, increasing the risk of liver damage.
• Anesthetics: Due to the effect on platelet aggregation and the theoretical risk of seizures, Borage can interact with various anesthetic agents used during surgery.

• High-Fat Meals: While some fat is needed for absorption, an excessively high-fat meal may lead to increased gastrointestinal distress and diarrhea when combined with Borage oil.
• Alcohol: As previously mentioned, alcohol increases the risk of hepatotoxicity and should be avoided.
• Garlic and Ginger: These foods have mild natural blood-thinning properties and may slightly increase the bleeding risk when consumed in large medicinal quantities alongside Borage.

• Omega-3 Fatty Acids (Fish Oil): While often taken together, high doses of both can significantly inhibit platelet aggregation. Monitoring for bruising is advised.
• Hepatotoxic Herbs (Kava, Comfrey, Skullcap): These should never be used with Borage, as they all pose risks to liver health.
• Vitamin E: High doses of Vitamin E can also have anti-coagulant effects, which may be additive to those of Borage.

Borage may interfere with the results of certain laboratory tests:

• Prothrombin Time (PT): May be prolonged.
• Liver Enzyme Tests: May show false elevations if the product is causing subclinical hepatic stress.
• Urine pH: As an acidifying agent, Borage may lower the pH of the urine, which can affect the results of tests for urinary tract infections or protein excretion.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete list is essential for preventing dangerous interactions.

Borage must NEVER be used in the following circumstances:

1. 1Pregnancy: Borage is absolutely contraindicated during pregnancy. The pyrrolizidine alkaloids (PAs) are known teratogens (cause birth defects) and can cause premature labor. Even PA-free oil is discouraged due to its effects on prostaglandin synthesis, which is critical for fetal development.
2. 2Active Liver Disease: Individuals with hepatitis, cirrhosis, or any form of liver failure must not use Borage. The metabolic demand placed on the liver by the fatty acids, combined with the risk of trace PA toxicity, can be fatal in these patients.
3. 3History of Seizures: Because Borage can lower the seizure threshold, it is contraindicated in patients with epilepsy or those who have had a seizure in the past.
4. 4Hypersensitivity: Anyone with a known allergy to Borage or other members of the Boraginaceae family should avoid all forms of the extract.

Conditions requiring careful risk-benefit analysis by a healthcare provider:

• Bleeding Disorders: Patients with hemophilia or von Willebrand disease should generally avoid Borage due to its anti-coagulant properties.
• Scheduled Surgery: Borage should be stopped at least 14 days before any surgery to prevent excessive perioperative bleeding.
• Schizophrenia: Because some medications used to treat schizophrenia (phenothiazines) interact poorly with Borage, its use in this population is generally discouraged.

Patients who are allergic to the following may also react to Borage:

• Comfrey (*Symphytum officinale*)
• Heliotrope
• Ragweed and Daisies (Asteraceae family) due to potential environmental cross-contamination or shared allergenic proteins.

> Important: Your healthcare provider will evaluate your complete medical history before prescribing or recommending Borage. Do not self-initiate treatment if you have any of the conditions listed above.

Borage is classified as Category X by many clinical references regarding its use in pregnancy. It is considered unsafe. The primary concern is the presence of pyrrolizidine alkaloids, which are known to be abortifacient (induce abortion) and teratogenic (cause fetal malformation). Furthermore, Borage oil's influence on prostaglandin levels can interfere with the maintenance of the uterine lining and fetal circulation. Pregnant women should avoid all forms of Borage, including topical applications, as some absorption can still occur through the skin.

Borage is not recommended for women who are breastfeeding. Pyrrolizidine alkaloids can pass into breast milk and pose a significant risk of liver damage to the nursing infant. There is also limited data on how high concentrations of GLA in breast milk might affect an infant's developing immune system and fatty acid balance. If Borage use is deemed medically necessary for the mother, breastfeeding should be discontinued.

Borage is not FDA-approved for any indication in children. While some clinicians use it off-label for pediatric eczema, this practice is controversial. Children are much more susceptible to the toxic effects of pyrrolizidine alkaloids than adults. If used, it must be under the strict guidance of a pediatric specialist who can ensure the product is PA-free and monitor the child's liver function closely. Growth effects have not been formally studied, but any substance that alters prostaglandin pathways should be used with extreme caution in developing bodies.

In patients over the age of 65, Borage should be used with heightened caution. The elderly are at an increased risk for:

• Fall-related bleeding: Since Borage thins the blood, a fall could result in a more serious internal hemorrhage.
• Reduced Clearance: Age-related declines in liver and kidney function mean that Borage metabolites may stay in the system longer, increasing the risk of side effects.
• Polypharmacy: Elderly patients are more likely to be on multiple medications (like blood pressure or heart medicine) that could interact with Borage.

For patients with a Glomerular Filtration Rate (GFR) below 30 mL/min, Borage should be used very cautiously. While not primarily cleared by the kidneys, its acidifying and chelating properties can alter the mineral balance in patients who already struggle with electrolyte regulation. Dialysis clearance of Borage constituents is unknown; therefore, it is generally avoided in patients on hemodialysis.

Borage is contraindicated in patients with Child-Pugh Class B or C hepatic impairment. In patients with mild impairment (Class A), the risk of exacerbating liver stress usually outweighs the potential benefits of the supplement. If a physician decides the benefit is sufficient, LFTs should be performed every 2-4 weeks during the initial phase of treatment.

> Important: Special populations require individualized medical assessment. Never assume a botanical product is safe just because it is 'natural.'

Borage's primary therapeutic effect is derived from its high concentration of gamma-linolenic acid (GLA). Once ingested, GLA is rapidly converted by the enzyme delta-6-desaturase (or bypassed if taken as GLA) and then elongated to dihomo-gamma-linolenic acid (DGLA). DGLA competes with arachidonic acid for the enzymes cyclooxygenase (COX) and 15-lipoxygenase (15-LOX).

Unlike arachidonic acid, which produces pro-inflammatory series-2 prostaglandins and series-4 leukotrienes, DGLA is converted into prostaglandin E1 (PGE1) and 15-hydroxyeicosatrienoic acid (15-HETrE). PGE1 increases intracellular cyclic AMP (cAMP), which inhibits the release of lysosomal enzymes, reduces the production of superoxide radicals, and inhibits the activation of nuclear factor-kappa B (NF-κB), a key regulator of the inflammatory response.

The pharmacodynamic effect of Borage is characterized by a slow onset. Because it works by altering the fatty acid composition of cell membranes, it takes several weeks for the 'anti-inflammatory' lipid profile to become dominant. The duration of effect can last for several days after discontinuation as the fatty acids are slowly turned over in the cellular membranes. Tolerance does not typically develop, but the efficacy is highly dependent on the baseline fatty acid status of the patient.

| Parameter | Value |

|---|---|

| Bioavailability | 60-80% (Oral) |

| Protein Binding | >95% (Albumin/Lipoproteins) |

| Half-life | 12-24 hours (GLA/DGLA) |

| Tmax | 2-4 hours |

| Metabolism | Hepatic; Elongation and Desaturation |

| Excretion | Sebum (Minor), Fecal (Unabsorbed), Renal (Metabolites) |

• Molecular Formula (GLA): C18H30O2
• Molecular Weight: 278.43 g/mol
• Solubility: Highly soluble in organic solvents and lipids; insoluble in water.
• Structure: Borage oil consists of triglycerides where the fatty acid chains include GLA (18:3 n-6), linoleic acid (18:2 n-6), and oleic acid (18:1 n-9).

Borage is classified as a Non-Standardized Plant Allergenic Extract [EPC]. Within the therapeutic area of rheumatology and dermatology, it is often grouped with other 'Essential Fatty Acid' supplements or 'Disease-Modifying Anti-Rheumatic Drugs (DMARDs)' of botanical origin, such as Evening Primrose Oil and Black Currant Seed Oil.